Chenguang Biotech Group (300138) — Free Cash Flow Generation Index

Latest as of September 2025: 0.93x

Chenguang Biotech Group (300138) has a Free Cash Flow Generation Index of 0.93x as of September 2025. Free cash flow of CN¥487.33 Million represents 1% of operating cash flow (CN¥524.96 Million). See how liquid is Chenguang Biotech Group's working capital to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.93x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥487.33 Million
CNY

Operating Cash Flow

CN¥524.96 Million
CNY

Capital Expenditures

CN¥37.63 Million
CNY

Chenguang Biotech Group Free Cash Flow Generation Index (2008–2022)

Historical FCF Generation Index trend for Chenguang Biotech Group across 7 annual periods. Explore 300138 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Chenguang Biotech Group (2008–2022)

Year-by-year Free Cash Flow Generation Index for Chenguang Biotech Group. For the full company profile including market capitalisation, see 300138 company net worth.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2022 0.76x CN¥558.78 Million CN¥734.81 Million CN¥176.03 Million ▲ +122.4%
2021 -3.39x CN¥-216.92 Million CN¥63.90 Million CN¥280.82 Million ▼ -2042.1%
2020 0.17x CN¥92.54 Million CN¥529.41 Million CN¥436.88 Million ▼ -79.8%
2014 0.87x CN¥236.33 Million CN¥272.96 Million CN¥36.62 Million ▲ +171.5%
2011 -1.21x CN¥-99.54 Million CN¥82.18 Million CN¥181.72 Million ▲ +16.8%
2009 -1.46x CN¥-39.67 Million CN¥27.23 Million CN¥66.90 Million ▲ +22.3%
2008 -1.87x CN¥-16.99 Million CN¥9.06 Million CN¥26.05 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).